Bacteria of, the genus Halobacterium lack the peptidoglycan layer characteristic of the walls of most prokaryotic organisms (Larsen, I 967). The major carbohydrate-containing component of the envelope of H. salinarium is a high molecular weight glycoprotein (Mescher, Strominger & Watson, 1974) which may play a role in maintaining the structural integrity of the envelope (Mescher et al. 1974) . Similar glycoproteins appear to be present in the envelopes of H. cutirubrum (unpublished results) and H. halobium (Koncewicz, 1972) . Conflicting reports have appeared regarding inhibition of the growth of Halobacteria by penicillin G (Cho, Doy & Mercer, 1967; Mohr & Larsen, 1963) , a specific inhibitor of the transpeptidase and carboxypeptidase activities of peptidoglycan synthesis (Strominger, 1970) . Since Halobacteria lack peptidoglycan, the ability of Na-penicillin G to inhibit their growth was re-examined. Ampicillin and cephalosporin C, which inhibit these same activities (Gale et al. 1972) , were also tested together with several antibiotics which interfere with other steps in the pathway of peptidoglycan synthesis. These included : ~-cycloserine, which inhibits the conversion of L-alanine to D-alanine and the formation of D-alanyl-Dalanine (Gale et al. 1972) ; bacitracin, which inhibits the dephosphorylation of C,,-isoprenyl pyrophosphate (Siewert & Strominger, I 967) ; and vancomycin, ristocetin (Gale et al. 1972; Strominger, 1970) , moenomycin (Lugtenberg, van Schijndel-van Dam & van Bellegem, 1971 ) and janiemycin (Linnett & Strominger, 1973) , all of which appear to inhibit the transfer of the disaccharide-pentapeptide unit from the lipid intermediate to the accept or.
METHODS
The organisms used were Halobacterium salinarium, strain I (ATCCI 9700), H. halobium (NRC34003) and H. cutirubrum (NRC34001). All strains were grown in the liquid medium previously described for growth of H. salinarium (Mescher et al. 1974) . The concentrations of the antibiotics required to give 50 % inhibition of growth are shown in Table I . All of the antibiotics tested, with one exception, either caused no inhibition at
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Sh ovt communication the maximum concentration tested or caused inhibition at concentrations 100 to 10000 times greater than those required for inhibition of bacteria possessing peptidoglycan. The inhibition observed at these extremely high concentrations was probably non-specific and unrelated to the specific effects of the antibiotics on peptidoglycan synthesis in normal bacteria.
The striking exception was bacitracin, which inhibited the growth of Halobacteria at concentrations comparable to those required for normal bacteria. Further examination of the effect of bacitracin showed that it caused a morphological change in the bacteria. Addition of bacitracin (30pglml) to cultures which had entered the exponential phase of growth decreased the growth rate and growth stopped after approximately one doubling (as measured by a Klett photometer) whereas control cultures without added bacitracin continued to grow for more than two doublings. Cultures were examined by phase contrast microscopy at various times after addition of bacitracin (Fig. I) . Organisms in the control culture (no bacitracin) were rod-shaped at all times examined (Fig. ra) . Organisms inhibited by bacitracin gradually changed from the normal rod shape to spherical forms. Complete conversion to spherical forms occurred only after growth in bacitracin for approximately one doubling time (about 30 h). Similar results were obtained with both H. halobiunz and H . cutirubrum.
While several effects of bacitracin on bacterial membranes have been reported (Weinberg, 1967) , Storm & Strominger (1973 have clearly shown that it specifically formsa complex with the C,,-isoprenyl pyrophosphate, thus inhibiting peptidoglycan synthesis, and have strongly suggested that this is its primary effect in the inhibition of bacterial growth. The low concentration of bacitracin required to inhibit Halobacteria and its effect on their morphology suggest that it may act by inhibiting the synthesis of a structural component of their envelope. There is now considerable evidence that the synthesis of at least some of the glycoproteins in eukaryotic organisms involves polyisoprenol phosphate intermediates (Behrens, I 974). Moreover, preliminary results suggest that the synthesis of the H . salinarium envelope glycoprotein also involves a polyisoprenyl pyrophosphate-linked intermediate, and bacitracin may therefore inhibit growth of Halobacteria and cause Short commun icat ion 377 conversion to spherical forms by inhibiting the synthesis of this glycoprotein as a consequence of forming a complex with polyisoprenyl pryophosphate. Bacitracin may also alter the lipid composition of the membrane to some extent by inhibiting synthesis of saturated isoprenoid chains of the type known to be present in at least one of the lipids of H. cutirubrunt (Kates, Yengoyan & Sastry, 1965) . These results show that a number of antibiotics thought specifically to affect peptidoglycan synthesis at several different points in the biosynthetic pathway do not inhibit the growth of Halobacteria. An exception to this rule is bacitracin; the morphological changes which accompany growth inhibition and the nature of the components of the Halobacteria envelope suggest that the mode of action of bacitracin in inhibiting these bacteria may to some extent be similar to its mode of action in bacteria possessing peptidoglycan. This investigation was supported by research grants from the U.S. Public Health Service (AM-I 3230) and from the National Science Foundation (GB-29747).
